These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Netilmicin in the treatment of bacterial respiratory tract infections]. Wandzilak M, Głuszko P, Królikowski W, Prokop A, Soja J, Szczeklik A. Pol Tyg Lek; ; 45(36-37):749-51. PubMed ID: 2084631 [Abstract] [Full Text] [Related]
11. [Clinical study of 25 patients treated with cefoperazone, a 3d generation cephalosporin]. Clément M, Regamey C. Rev Med Suisse Romande; 1982 Sep; 102(9):833-8. PubMed ID: 6216572 [No Abstract] [Full Text] [Related]
12. An open evaluation of the efficacy and safety of the new macrolide roxithromycin in the treatment of lower respiratory tract infections and pneumonia in Nigerian patients. Isah AO, Ohaju-Obodo J. West Afr J Med; 1996 Sep; 15(2):111-6. PubMed ID: 8855675 [Abstract] [Full Text] [Related]
16. [Cefotaxime in bronchopulmonary infections (author's transl)]. Kermarec J, Sauvaget J. Nouv Presse Med; 1981 Feb 26; 10(8):650-3. PubMed ID: 6259612 [Abstract] [Full Text] [Related]
17. [Clinical evaluation of cefoperazone in lower respiratory tract infections]. Ishibashi T, Takamoto M, Shinoda A, Matsuba K, Yoshida M, Ichikawa Y, Ando M, Matsuzaki Y, Kitahara Y, Hara N. Jpn J Antibiot; 1986 Oct 26; 39(10):2780-94. PubMed ID: 3543433 [Abstract] [Full Text] [Related]
19. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms. Covi M, Velluti G. J Chemother; 1995 Jun 26; 7 Suppl 2():137-42. PubMed ID: 8622102 [Abstract] [Full Text] [Related]
20. [Cefoperazone--Possibility of safer treatment for infections in patients with chronic renal failure]. Klinger M, Szewczyk Z, Kazimierczak K, Kramarz S. Wiad Lek; 1995 Jun 26; 43(15-16):773-6. PubMed ID: 2275197 [Abstract] [Full Text] [Related] Page: [Next] [New Search]